Prostate cancer study reveals molecular switch linked to lineage plasticity, therapy resistance

Medicine Research News News

Prostate cancer study reveals molecular switch linked to lineage plasticity, therapy resistance
Medicine ResearchHealth Research NewsHealth Research
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.

Prostate cancer study reveals molecular switch linked to lineage plasticity, therapy resistance retrieved 5 June 2024 from https://medicalxpress.com/news/2024-06-prostate-cancer-reveals-molecular-linked.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brainUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Medicine Research Health Research News Health Research Health Science Medicine Science

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Prostate cancer screening: Longer screening intervals are safe with low baseline prostate-specific antigenProstate cancer screening: Longer screening intervals are safe with low baseline prostate-specific antigenRisk-adjusted screening strategies for prostate cancer should help to ensure that fewer men are tested unnecessarily often. According to the experts, this can reduce over-diagnosis and over-treatment, which can cause more harm than good.
Read more »

'Brilliant' medical professor and father-of-two, 43, died following botched treatment for a rare...'Brilliant' medical professor and father-of-two, 43, died following botched treatment for a rare...Prof Amit Patel suffered massive internal bleeding following a procedure for a rare condition and a coroner said Prof Patel's death was caused by 'failures in his care' and his death was 'avoidable'.
Read more »

'Brilliant' medical professor and father-of-two, 43, died following botched treatment for a rare...'Brilliant' medical professor and father-of-two, 43, died following botched treatment for a rare...Prof Amit Patel suffered massive internal bleeding following a procedure for a rare condition and a coroner said Prof Patel's death was caused by 'failures in his care' and his death was 'avoidable'.
Read more »

JUN protein could slow prostate cancer growth, study findsJUN protein could slow prostate cancer growth, study findsAs prostate cancer progresses, it becomes increasingly aggressive and can metastasise. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate is the second most common cause of cancer death in men.
Read more »

Study finds first-line biparametric MRI less cost-effective than PSA for prostate cancer screeningStudy finds first-line biparametric MRI less cost-effective than PSA for prostate cancer screeningFrom an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to false-positive results and overdiagnosis, according to a study published online June 4 in the Annals of Internal Medicine.
Read more »

Study confirms effectiveness of 'watch-and-wait' approach to prostate cancerStudy confirms effectiveness of 'watch-and-wait' approach to prostate cancerFor a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a 'watch-and-wait' approach instead of active treatment.
Read more »



Render Time: 2025-02-22 01:28:24